Global Dry Eye Syndrome Treatment Market

Global Dry Eye Syndrome Treatment Market Size, Share, Growth Analysis, By Product(Artificial tears, anti-inflammatory drugs), By Distribution channel(Hospitals, clinics) - Industry Forecast 2024-2031


Report ID: SQMIG35D2131 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 65 | Figures: 75

Global Dry Eye Syndrome Treatment Market Insights

Dry Eye Syndrome Treatment Market size was valued at USD 6.61 billion in 2022 and is poised to grow from USD 7.07 billion in 2023 to USD 11.36 billion by 2030, at a CAGR of 7.0% during the forecast period (2023-2030).

The global dry eye syndrome treatment market has witnessed significant growth in recent years due to the rising prevalence of dry eye disease and an aging population.

Increased awareness about the condition, technological advancements in diagnostic tools, and a growing focus on patient comfort have also contributed to market expansion.

Pharmaceutical interventions, including artificial tears, anti-inflammatory drugs, and immunomodulators, remain the primary treatment options.

Additionally, there is a growing trend towards adopting advanced therapies, such as regenerative medicine and gene therapy, which shows promising potential in addressing the underlying causes of the condition.

The market is expected to continue its growth trajectory in the coming years as research and development efforts further enhance treatment efficacy.

US Dry Eye Syndrome Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.

To get more reports on the above market click here to Buy The Report

Global Dry Eye Syndrome Treatment Market Segmental Analysis

The global dry eye syndrome treatment market can be segmented based on product type, distribution channel, and region. In terms of product type, it includes artificial tears, anti-inflammatory drugs, punctal plugs, and others. Distribution channels comprise hospitals, clinics, retail pharmacies, and e-commerce platforms. Geographically, the market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Dry Eye Syndrome Treatment Market Analysis By Product

Artificial tears have emerged as the largest sector in the market, owing to their widespread usage for providing immediate relief from dry eye symptoms and easy accessibility as over-the-counter products. Additionally, the growing adoption of preservative-free artificial tears has further fueled their demand among patients, contributing to the dominant position of this segment.

On the other hand, the fastest-growing sector in the global dry eye syndrome treatment market is likely to be secretagogues. Secretagogues are a class of drugs that promote tear production by stimulating the lacrimal gland. With an increasing focus on developing novel and more effective treatments, pharmaceutical companies have been investing in research and development to enhance the efficacy of secretagogues.

Dry Eye Syndrome Treatment Market Analysis By Distribution Channel

Hospital pharmacies have emerged as the largest sector in this market, primarily due to the rising number of patients seeking medical attention for dry eye syndrome and the availability of specialized treatments in these healthcare settings. Hospitals often house well-equipped eye care facilities, attracting a significant number of patients seeking immediate relief and long-term management of the condition.

On the other hand, the fastest-growing sector in this market is the online platform distribution channel. This growth can be attributed to the increasing trend of consumers opting for the convenience of purchasing medications and treatments online, coupled with the wider availability of e-commerce platforms.

To get detailed analysis on other segments, Request For Free Sample Report

Global Dry Eye Syndrome Treatment Market Regional Insights

North America dominated the market due to high awareness, advanced healthcare infrastructure, and a large patient pool. Europe followed closely, driven by an aging population and increasing prevalence of dry eye cases.

Asia-Pacific witnessed rapid growth due to improving healthcare facilities and rising awareness. Latin America and the Middle East & Africa regions exhibited steady progress, bolstered by increasing healthcare investments. However, ongoing research and development efforts, along with technological advancements, continued to shape the market dynamics across all regions.

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Dry Eye Syndrome Treatment Market Dynamics

Dry Eye Syndrome Treatment Market Drivers

Increased Screen Time to Bolster Market Growth

  • The growing prevalence of dry eye syndrome (DES) worldwide is a significant driver propelling the growth of the global dry eye syndrome treatment market. Factors such as increasing screen time due to digitalization, aging population, environmental pollution, and lifestyle changes have contributed to a higher incidence of DES. As a result, there is a rising demand for effective and innovative treatment options, including artificial tears, anti-inflammatory medications, and punctal plugs, driving the market's expansion.

Dry Eye Syndrome Treatment Market Restraints

Diverse Results Lead to Uncertainty of the Treatment

  • One key restraint facing the global dry eye syndrome treatment market is the lack of a one-size-fits-all treatment approach. Dry eye syndrome is a complex condition with diverse underlying causes, including aqueous deficiency, evaporative dysfunction, and mixed mechanisms. Consequently, the effectiveness of a specific treatment may vary significantly from one patient to another. The absence of a universally effective treatment can lead to prolonged trial and error for patients, resulting in frustration and delayed relief. Additionally, the diverse nature of the condition poses challenges for pharmaceutical companies in developing novel therapies that cater to the unique needs of individual patients, further limiting the market's potential growth.

Request Free Customization of this report to help us to meet your business objectives.

Global Dry Eye Syndrome Treatment Market Competitive Landscape

The global dry eye syndrome treatment market is characterized by intense competition among key players striving to gain a competitive edge. Established pharmaceutical companies and innovative biotech firms are engaged in continuous research and development to introduce advanced therapies and novel treatment options. Additionally, strategic collaborations, mergers, and acquisitions are prevalent in the market to expand product portfolios and enhance global market presence. Factors such as rising awareness of dry eye syndrome, an aging population, and technological advancements contribute to the market's growth, fostering a highly competitive landscape focused on addressing patient needs effectively.

Dry Eye Syndrome Treatment Market Top Player’s Company Profiles

  • Otsuka Holdings Co., Ltd. - Japan
  • Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) - Canada
  • Johnson & Johnson - USA
  • Shire (now part of Takeda Pharmaceutical Company Limited) - Ireland
  • Alcon (formerly part of Novartis) - Switzerland
  • Sun Pharmaceutical Industries Ltd. - India
  • Aerie Pharmaceuticals, Inc. - USA
  • Nicox S.A. - France
  • Akorn Pharmaceuticals - USA
  • Aurohealth - USA
  • Kala Pharmaceuticals, Inc. - USA
  • Auven Therapeutics (Now part of Sun Pharmaceutical Industries Ltd.) - USA
  • Bridge Pharma, Inc. - USA
  • Hanall Pharmaceutical Co., Ltd. - South Korea
  • Horus Pharma - France
  • Novagali Pharma S.A. (Now part of Santen Pharmaceutical Co., Ltd.) - France
  • Mitotech S.A. – Luxembourg

Dry Eye Syndrome Treatment Market Recent Developments

  • In August, 2022. CyclASol (cyclosporine ophthalmic solution), a topical anti-inflammatory and immunomodulating ophthalmic medication solution designed for the treatment of dry eye illness, was filed as a New medication Application (NDA) to the U.S. FDA.

Global Dry Eye Syndrome Treatment Key Market Trends

  • There was a growing preference for preservative-free eye drops and artificial tears due to increased awareness about potential side effects of preservatives.
  • Advancements in technology led to the development of innovative and targeted therapies, such as topical corticosteroids and novel anti-inflammatory drugs.
  • The market saw a rising demand for over the counter (OTC) treatments, driven by ease of accessibility and convenience. Moreover, the integration of digital health solutions and telemedicine services played a significant role in improving patient management and adherence to treatment plans.

Global Dry Eye Syndrome Treatment Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analysis, the global dry eye syndrome treatment market shows promising future prospects as it continues to witness significant growth and advancements in medical technologies. With an aging population, rising prevalence of chronic diseases, and increasing awareness about eye health, the demand for effective dry eye treatments is expected to surge. Additionally, ongoing research and development efforts in the pharmaceutical and biotechnology sectors are likely to introduce innovative therapeutic options, driving market expansion. The adoption of personalized medicine approaches, such as gene therapies and regenerative medicine, may also revolutionize dry eye treatments. Furthermore, the integration of artificial intelligence and telemedicine in eye care services could enhance early diagnosis and personalized treatment plans. Despite potential challenges, such as stringent regulatory requirements and market competition, the dry eye syndrome treatment market is poised for substantial growth and offers lucrative opportunities for industry players in the coming years.

Report Metric Details
Market size value in 2023 USD 6.61 billion
Market size value in 2031 USD 11.36 billion
Growth Rate 7.0%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Artificial tears, anti-inflammatory drugs, punctal plugs, and others
  • Distribution channel
    • Hospitals, clinics, retail pharmacies, and e-commerce platforms
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Otsuka Holdings Co., Ltd. - Japan
  • Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) - Canada
  • Johnson & Johnson - USA
  • Shire (now part of Takeda Pharmaceutical Company Limited) - Ireland
  • Alcon (formerly part of Novartis) - Switzerland
  • Sun Pharmaceutical Industries Ltd. - India
  • Aerie Pharmaceuticals, Inc. - USA
  • Nicox S.A. - France
  • Akorn Pharmaceuticals - USA
  • Aurohealth - USA
  • Kala Pharmaceuticals, Inc. - USA
  • Auven Therapeutics (Now part of Sun Pharmaceutical Industries Ltd.) - USA
  • Bridge Pharma, Inc. - USA
  • Hanall Pharmaceutical Co., Ltd. - South Korea
  • Horus Pharma - France
  • Novagali Pharma S.A. (Now part of Santen Pharmaceutical Co., Ltd.) - France
  • Mitotech S.A. – Luxembourg
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Dry Eye Syndrome Treatment Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Dry Eye Syndrome Treatment Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Dry Eye Syndrome Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Dry Eye Syndrome Treatment Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Dry Eye Syndrome Treatment Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Dry Eye Syndrome Treatment Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Dry Eye Syndrome Treatment Market size was valued at USD 6.61 billion in 2022 and is poised to grow from USD 7.07 billion in 2023 to USD 11.36 billion by 2030, at a CAGR of 7.0% during the forecast period (2023-2030).

The global dry eye syndrome treatment market is characterized by intense competition among key players striving to gain a competitive edge. Established pharmaceutical companies and innovative biotech firms are engaged in continuous research and development to introduce advanced therapies and novel treatment options. Additionally, strategic collaborations, mergers, and acquisitions are prevalent in the market to expand product portfolios and enhance global market presence. Factors such as rising awareness of dry eye syndrome, an aging population, and technological advancements contribute to the market's growth, fostering a highly competitive landscape focused on addressing patient needs effectively. 'Allergan, Inc. (Now AbbVie Inc.) - USA', 'Novartis AG - Switzerland', 'Santen Pharmaceutical Co., Ltd. - Japan', 'Otsuka Holdings Co., Ltd. - Japan', 'Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) - Canada', 'Johnson & Johnson - USA', 'Shire (now part of Takeda Pharmaceutical Company Limited) - Ireland', 'Alcon (formerly part of Novartis) - Switzerland', 'Sun Pharmaceutical Industries Ltd. - India', 'Aerie Pharmaceuticals, Inc. - USA', 'Nicox S.A. - France', 'Akorn Pharmaceuticals - USA', 'Aurohealth - USA', 'Kala Pharmaceuticals, Inc. - USA', 'Auven Therapeutics (Now part of Sun Pharmaceutical Industries Ltd.) - USA', 'Bridge Pharma, Inc. - USA', 'Hanall Pharmaceutical Co., Ltd. - South Korea', 'Horus Pharma - France', 'Novagali Pharma S.A. (Now part of Santen Pharmaceutical Co., Ltd.) - France', 'Mitotech S.A. – Luxembourg'

The growing prevalence of dry eye syndrome (DES) worldwide is a significant driver propelling the growth of the global dry eye syndrome treatment market. Factors such as increasing screen time due to digitalization, aging population, environmental pollution, and lifestyle changes have contributed to a higher incidence of DES. As a result, there is a rising demand for effective and innovative treatment options, including artificial tears, anti-inflammatory medications, and punctal plugs, driving the market's expansion.

There was a growing preference for preservative-free eye drops and artificial tears due to increased awareness about potential side effects of preservatives.

North America dominated the market due to high awareness, advanced healthcare infrastructure, and a large patient pool. Europe followed closely, driven by an aging population and increasing prevalence of dry eye cases.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Dry Eye Syndrome Treatment Market

Product ID: SQMIG35D2131

$5,300
BUY NOW GET FREE SAMPLE